JP7121418B2 - 局所的な虚血－再灌流により誘発される細胞死の新型なアミノチオールによる減少 - Google Patents
局所的な虚血－再灌流により誘発される細胞死の新型なアミノチオールによる減少 Download PDFInfo
- Publication number
- JP7121418B2 JP7121418B2 JP2020554358A JP2020554358A JP7121418B2 JP 7121418 B2 JP7121418 B2 JP 7121418B2 JP 2020554358 A JP2020554358 A JP 2020554358A JP 2020554358 A JP2020554358 A JP 2020554358A JP 7121418 B2 JP7121418 B2 JP 7121418B2
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- organ
- use according
- prc
- reperfusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Biophysics (AREA)
- Physiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862710838P | 2018-03-01 | 2018-03-01 | |
| US62/710,838 | 2018-03-01 | ||
| PCT/CN2019/070444 WO2019165851A1 (en) | 2018-03-01 | 2019-01-04 | Novel aminothiol reduction of ischemia-reperfusion-induced cell death |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021506982A JP2021506982A (ja) | 2021-02-22 |
| JP2021506982A5 JP2021506982A5 (enrdf_load_stackoverflow) | 2021-04-01 |
| JP7121418B2 true JP7121418B2 (ja) | 2022-08-18 |
Family
ID=67805623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554358A Active JP7121418B2 (ja) | 2018-03-01 | 2019-01-04 | 局所的な虚血－再灌流により誘発される細胞死の新型なアミノチオールによる減少 |
Country Status (8)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL310131A (en) * | 2021-07-16 | 2024-03-01 | Obvia Pharmaceuticals Ltd | Prc-210 for use in the treatment of acute tissue injury |
| WO2024168231A1 (en) * | 2023-02-10 | 2024-08-15 | Obvia Pharmaceuticals, Ltd. | Aminothiols for the treatment of conditions characterized by protein misfolding or aggregation, mitochondrial dysfunction, or chronic inflammation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6031006A (en) * | 1999-10-21 | 2000-02-29 | Bionumerik Pharmaceuticals, Inc. | Method of treating diabetic nephropathy |
| WO2005014524A2 (en) | 2003-08-07 | 2005-02-17 | Wisconsin Alumni Research Foundation | Amino thiol compounds and compositions for use in conjunction with cancer therapy |
| WO2006011273A1 (ja) * | 2004-07-30 | 2006-02-02 | Japan Science And Technology Agency | 虚血後の再灌流性細胞死の抑制方法、および細胞死抑制剤 |
| WO2017004485A1 (en) * | 2015-07-02 | 2017-01-05 | Raptor Pharmaceuticals Inc. | Ado-resistant cysteamine analogs and uses thereof |
-
2019
- 2019-01-04 US US16/629,851 patent/US11690813B2/en active Active
- 2019-01-04 AU AU2019228134A patent/AU2019228134B2/en active Active
- 2019-01-04 WO PCT/CN2019/070444 patent/WO2019165851A1/en unknown
- 2019-01-04 KR KR1020207026024A patent/KR102490204B1/ko active Active
- 2019-01-04 CN CN201980011285.XA patent/CN111801095A/zh active Pending
- 2019-01-04 CA CA3092596A patent/CA3092596C/en active Active
- 2019-01-04 EP EP19760716.1A patent/EP3758691A4/en not_active Withdrawn
- 2019-01-04 EP EP25151058.2A patent/EP4588472A1/en active Pending
- 2019-01-04 JP JP2020554358A patent/JP7121418B2/ja active Active
Non-Patent Citations (3)
| Title |
|---|
| Cardiovascular Research，2000年，Vol.47,No.3，p.446-456 |
| Int J Radiat Biol.，2013年，Vol.89,No.7，p.485-492 |
| Oxidative Medicine and Cellular Longevity，2017年，Vol.2017，Article ID: 4130824, p.1-12 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019165851A1 (en) | 2019-09-06 |
| US20210299066A1 (en) | 2021-09-30 |
| CA3092596C (en) | 2024-05-21 |
| AU2019228134B2 (en) | 2022-03-03 |
| US11690813B2 (en) | 2023-07-04 |
| CA3092596A1 (en) | 2019-09-06 |
| EP3758691A1 (en) | 2021-01-06 |
| KR102490204B1 (ko) | 2023-01-19 |
| KR20200118851A (ko) | 2020-10-16 |
| CN111801095A (zh) | 2020-10-20 |
| EP4588472A1 (en) | 2025-07-23 |
| JP2021506982A (ja) | 2021-02-22 |
| AU2019228134A1 (en) | 2020-10-22 |
| EP3758691A4 (en) | 2021-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010226894B2 (en) | Organ arrest, protection, preservation and recovery | |
| Mendes-Braz et al. | The current state of knowledge of hepatic ischemia‐reperfusion injury based on its study in experimental models | |
| KR20240051283A (ko) | 산소첨가된 콜레스테롤 술페이트 (ocs) 의 용도 | |
| KR20160070077A (ko) | 안구내 투여를 위한 에피네프린-기반 안과용 조성물 및 이의 제조 방법 | |
| JP7121418B2 (ja) | 局所的な虚血－再灌流により誘発される細胞死の新型なアミノチオールによる減少 | |
| ES2906262T3 (es) | Composiciones para el tratamiento de la autodigestión | |
| US20180042873A1 (en) | Novel methods | |
| JP2017535546A5 (enrdf_load_stackoverflow) | ||
| US20080089947A1 (en) | Calcium Influx Inhibitors in the Treatment of Ischemia | |
| ES2451349T3 (es) | Inhibidores de CXCR1/2 como adyuvantes en el trasplante de islotes pancreáticos | |
| KR20130096722A (ko) | 개선된 장기 이식체 보존 및 수용을 위한 조성물 및 방법 | |
| WO2016086327A1 (es) | Formulación antioxidante inyectable de uso intravenoso de ascorbato de sodio - en altas dosis, n-acetilcisteína, y deferoxamina; método de administración y uso en prevenir daño por reperfusión; y kit | |
| HK40031657A (en) | Novel aminothiol reduction of ischemia-reperfusion-induced cell death | |
| CN1210461A (zh) | 对活性氧组份不良反应的治疗和预防 | |
| Sadic et al. | Scintigraphic, histopathologic and biochemical evaluation of lycopene effects on renal ischemia reperfusion injury in rats | |
| FR2937550A1 (fr) | Utilisation de la citrulline pour le traitement et la prevention du syndrome d'ischemie-reperfusion | |
| JP2005500251A (ja) | 洞様毛細血管閉塞症候群および放射線療法誘発性肝疾患を予防および処置するための組成物および方法 | |
| PT1539213E (pt) | Terapêuticas cardioprotectoras baseadas na eliminação enzimática de peróxidos de lípidos por aleno óxido sintase | |
| Börcek et al. | Scintigraphic, histopathologic, and biochemical evaluation of lycopene effects on renal ischemia reperfusion injury in rats | |
| JP2007238466A (ja) | 虚血再灌流による内臓障害の抑制剤 | |
| HK1081109B (en) | Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200623 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200623 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210623 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20210915 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210922 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20210915 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211122 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20211122 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220419 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220520 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220712 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220729 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7121418 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |